Advances in prostate cancer immunotherapies
/in International Publications, Prostate Cancer /von 2007-01-01 / Drugs Aging 2007;24(3):197-221Vaccination of advanced prostate cancer patients with PSCA and PSA peptide-loaded dendritic cells induces DTH responses that correlate with superior overall survival
/in International Publications, Prostate Cancer /von 2006-11-15 / Int. J. Cancer 2006 Nov;119(10):2428-34Vaccination therapy in prostate cancer
/in International Publications, Prostate Cancer /von 2006-10-10 / Cancer Immunol. Immunother. 2007 Apr;56(4):429-45Immunotherapy for prostate cancer using prostatic acid phosphatase loaded antigen presenting cells
/in International Publications, Prostate Cancer /von 2006-09-01 / Urol. Oncol. 2006 Sep-Oct;24(5):434-41Basic overview of current immunotherapy approaches in urologic malignancy
/in International Publications, Prostate Cancer /von 2006-09-01 / Urol. Oncol. 2006 Sep-Oct;24(5):413-8Immunotherapy for prostate cancer: what’s the future?
/in International Publications, Prostate Cancer /von 2006-08-01 / Hematol. Oncol. Clin. North Am. 2006 Aug;20(4):965-83, xiVaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells: results of a phase I clinical trial
/in International Publications, Prostate Cancer /von 2006-06-01 / Prostate 2006 Jun;66(8):811-21Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma
/in Dendritic Cells, International Publications, Prostate Cancer /von 2006-04-13 / Cancer Immunol. Immunother. 2006 Dec;55(12):1524-33Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells
/in International Publications, Prostate Cancer /von 2006-04-13 / Cancer Immunol. Immunother. 2006 Nov;55(11):1432-42
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de